BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee HY, Hong IS. Targeting Liver Cancer Stem Cells: An Alternative Therapeutic Approach for Liver Cancer. Cancers (Basel). 2020;12. [PMID: 32987767 DOI: 10.3390/cancers12102746] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Li L, Chen A, Liu B, Pan H, Yu Y, Liu Y. Preparation and pharmacokinetics of glycyrrhetinic acid and cell transmembrane peptides modified with liposomes for liver targeted-delivery. Biomed Mater 2022;17. [PMID: 35483344 DOI: 10.1088/1748-605X/ac6b73] [Reference Citation Analysis]
2 Yin X, Chen H, Chen S, Zhang S, Korivi M. Screening and Validation of a Carvacrol-Targeting Viability-Regulating Protein, SLC6A3, in Liver Hepatocellular Carcinoma. Disease Markers 2022;2022:1-15. [DOI: 10.1155/2022/3736104] [Reference Citation Analysis]
3 Yu W, Ma Y, Shrivastava SK, Srivastava RK, Shankar S. Chronic alcohol exposure induces hepatocyte damage by inducing oxidative stress, SATB2 and stem cell‐like characteristics, and activating lipogenesis. J Cellular Molecular Medi. [DOI: 10.1111/jcmm.17235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li H, Sun Y, Li Q, Luo Q, Song G. Matrix Stiffness Potentiates Stemness of Liver Cancer Stem Cells Possibly via the Yes-Associated Protein Signal. ACS Biomater Sci Eng 2022. [PMID: 35084830 DOI: 10.1021/acsbiomaterials.1c00558] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Motofei IG. Biology of cancer; from cellular and molecular mechanisms to developmental processes and adaptation. Semin Cancer Biol 2021:S1044-579X(21)00253-4. [PMID: 34695580 DOI: 10.1016/j.semcancer.2021.10.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Sha X, Wang K, Wang F, Zhang C, Yang L, Zhu X. Silencing PFKP restrains the stemness of hepatocellular carcinoma cells. Exp Cell Res 2021;407:112789. [PMID: 34418458 DOI: 10.1016/j.yexcr.2021.112789] [Reference Citation Analysis]
7 He S, Tian S, He X, Le X, Ning Y, Chen J, Chen H, Mu J, Xu K, Xiang Q, Wu Y, Chen J, Xiang T. Multiple targeted self-emulsifying compound RGO reveals obvious anti-tumor potential in hepatocellular carcinoma. Mol Ther Oncolytics 2021;22:604-16. [PMID: 34589579 DOI: 10.1016/j.omto.2021.08.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Farina AR, Cappabianca LA, Zelli V, Sebastiano M, Mackay AR. Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting. World J Stem Cells 2021; 13(7): 685-736 [PMID: 34367474 DOI: 10.4252/wjsc.v13.i7.685] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Fatma H, Siddique HR. Pluripotency inducing Yamanaka factors: role in stemness and chemoresistance of liver cancer. Expert Rev Anticancer Ther 2021;21:853-64. [PMID: 33832395 DOI: 10.1080/14737140.2021.1915137] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Lin Z, Miao D, Xu Q, Wang X, Yu F. A novel focal adhesion related gene signature for prognostic prediction in hepatocellular carcinoma. Aging (Albany NY) 2021;13:10724-48. [PMID: 33850056 DOI: 10.18632/aging.202871] [Reference Citation Analysis]